The Trump administration recently announced a groundbreaking deal aimed at expanding access to and reducing the cost of weight loss…
Browsing: Novo
Metsera: The Weight Loss Startup That’s Turning Heads Metsera, a three-year-old mid-stage clinical obesity startup, has suddenly found itself in…
The Trump administration is reportedly in the final stages of negotiations with pharmaceutical giants Eli Lilly and Novo Nordisk to…
The battle against obesity has taken an unexpected turn, as Novo Nordisk has made a bold bid to acquire Metsera,…
Looking to the Future Novo Nordisk is facing significant challenges in the weight loss drug market, but with new leadership,…
A recent decision by a federal appeals court has upheld Medicare’s drug price negotiation program, allowing the government to group…
The recent attack on the Centers for Disease Control and Prevention (CDC) has raised concerns about security vulnerabilities within the…
When the FDA removed Novo Nordisk and Eli Lilly’s GLP-1 medications from the drug shortage list, it seemed like compounded…
Novo Nordisk’s obesity drug Wegovy has received approval from the U.S. Food and Drug Administration to treat metabolic dysfunction-associated steatohepatitis…
Novo Nordisk Teams Up with WeightWatchers to Offer Wegovy Through NovoCare Pharmacy In a groundbreaking collaboration, Novo Nordisk has partnered…
